Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia

NCT00711269 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: SM-13496 (lurasidone HCl)
DRUG: SM-13496 (lurasidone HCl)
DRUG: Placebo
DRUG: Risperidone

Sponsor

Sumitomo Pharma Co., Ltd.